ATS 2024 Final Program

Click on the session title to view the speakers

SUNDAY • MAY 19

37

507 The Dilemma of Patients Who “Age-out” of Lung Cancer Screening 508 Implementation of Navigator-Centric Lung Cancer Screening Program in a Large, Urban Safety Net Healthcare System 509 San Francisco Veterans Affairs Lung Cancer Screening Program: Impact of Recently Added Support From Veterans Health Administration’s Lung Precision Oncology Program 510 National Survey of Communication of Lung Cancer Screening Results in Veterans Health Administration Facilities 511 Stage Shift in Military Veterans Enrolled in Lung Cancer Screening Programs 512 Racial Disparity in Lung Cancer Screening and Detection Amongst Asians 513 A Tailored Decision Aid for Shared Decision Making Improves Understanding of Lung Cancer Screening in People With HIV 514 Inpatient Capture: A Community Based Mixed Methods Study to Develop an Inpatient Lung Cancer Screening Program at a Safety Net Hospital 515 Impact of a Secondary Review Process on a VA Lung Cancer Screening Program 516 Lung Cancer Screening for Individuals With Peutz Jeghers Syndrome 517 6 Month Follow Up of a Pilot Trial of Delayed Versus Immediate Financial Incentives for Smoking Cessation 518 Emergency Diagnosis of Lung Cancer Among Patients With Chronic Obstructive Pulmonary Disease in the United States 519 Association Between Race and Insurance Status With Follow-up Rates in Incidental Lung Nodules 520 Analysis of Demographics, Clinical Characteristics, and Outcome of Patients With Incidental Lung Nodules 521 Implementation and Impact of Virtual Multidisciplinary Consult Review on Timeliness of Care for Veterans With Thoracic Malignancy 522 Impact of Synoptic Reporting on Completeness of Systematic Endoscopic Lymph Node Sampling in Non-small Cell Lung Cancer Patients: A Post-hoc Analysis From the SEISMIC Study

523 Impact of Pretreatment Prognostic Nutritional Index (PNI) on Overall Survival in Patients With Metastatic Lung Cancer 524 Chronic Obstructive Pulmonary Disease Severity After Immune Checkpoint Inhibitor Treatment in Patients With Lung Cancer

BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

A31 IMMUNE CELL MOLECULAR

ACTIVATION SWITCH IN LUNG INJURY AND INFLAMMATION

9:15 a.m. - 4:15 p.m.

San Diego Convention Center Area D (Hall A-B2, Ground Level)

Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P329 Dendritic Cells Activation in the Lungs of Mice Exposed to Aerosols of Flavored Vaping Liquid P330 Single-cell RNA Sequencing Analysis of Oncostatin M-Oncostatin M Receptor Signaling in the Lungs P331 Nasal Aspirate Cytokine Levels in Children Hospitalized With Rhinovirus A and Rhinovirus C Infections P332 Poly I:C Led to the Recruitment of Immunomodulatory, M2-like Monocyte-derived Macrophages into the Lungs in a Murine Asthma Model P333 Dysregulation of Bmal1 in Airway Epithelial Cells Caused a Decrease in Response to Glucocorticoid in HDM-induced Asthma P334 Patients With Methamphetamine-induced Pulmonary Hypertension Display Derangement in DNA-sensing Pathway in Myeloid-derived Cells P335 The Functional Immune Effects of the Platelet Storage Lesion P336 Effect of Dietary Fat on Lung Injury in a Murine Lung Ischemia-Reperfusion Model P337 Sleep Fragmentation Disrupts the Immune Landscape in the Murine Lungs

ATS 2024 Conference Program • San Diego, CA